44results about How to "Altered function" patented technology

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

The present invention relates to compositions and methods for treating infectious diseases and genetic disorders through gene therapy and intracellular delivery of antisense oligonucleotides or other nucleic acid sequences. The present invention comprises a therapeutic delivery composition effective for treating a disease state comprising an administerable admixture of an effective amount of a therapeutic compound capable of altering nucleic acid sequence function and an effective amount of a block copolymer having the following general formula: 1 wherein: the mean aggregate molecular weight of the portion of the octablock copolymer represented by polyoxypropylene is between about 5000 and about 7000 Daltons; a is a number such that the portion represented by polyoxyethylene constitutes between about 10% to about 40% of the compound by weight; and b is a number such that the polyoxypropylene portion of the total molecular weight of the octablock copolymer constitutes between about 60% and about 90% of the compound by weight. The present invention also includes compositions and methods using biologically active nonionic reverse block copolymers. The reverse copolymers have an inner core of polyoxypropylene (POP) that is flanked on either end by polyoxyethylene (POE). The reverse block copolymers have the following formula: 2 wherein "b" represents a number such that the molecular weight of the hydrophobe (C.sub.3H.sub.6O).sub.b is between approximately 2,000 and 10,000, and "a" represents a number such that the percentage of hydrophile (C.sub.2H.sub.4O).sub.a is between approximately 5% and 30%.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

The present invention relates to use of particular substituted heterocycle fused gamma-carbolines as described herein, in free, pharmaceutically acceptable salt or prodrug form, and pharmaceutical composition comprising the same optionally in combination with one or more agents, for the prophylaxis or treatment of one or more disorders associated with dementia, particularly behavioral or mood disturbances (e.g., agitation / aggression), psychosis, depression and sleep disturbances among others in patients suffering from dementia.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a method includes detecting that a security compromise event has occurred for a mobile device. The method also includes altering a function of the mobile device in response to the security compromise event to mitigate loss of control by an authorized user. Altering the function of the mobile device includes denying access to data stored on the mobile device.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for addressing devices that have low or no power.

Systems and methods for generating high velocity mass air flows are disclosed. High velocity mass air flow (air charging) devices are needed in a variety of research, industrial, commercial, and consumer applications. The exemplary systems and apparatus described incorporate an electric motor subassembly, an air effector subassembly, a highly intelligent apparatus controller subassembly (and interfaces), and linked sensors, connectors, and wiring. The exemplary method described includes the operational apparatus controller subassembly (e.g., elements, logic, and behavior) that controls the entire apparatus' functions and interactions.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

A warming system, mounted to the foot of a bed, warms a person's lower extremities by directing air into the space between the mattress and overlaying blankets. A blower directs air into an elongated distribution chamber having many tiny exit apertures. The chamber is mounted at the foot of the bed, so that air exiting the apertures warms the person's feet. For maximum thermal transfer, the chamber is placed under the sheet and any blankets, but above the mattress cover and fitted sheet. The chamber may be implemented by a length of open cell foam, a hollow manifold with many punctures or other tiny distribution apertures, collapsible pocket, etc. While the person is lying on the bed beneath the blankets, with feet proximate the foot of the bed, the blower directs temperature-regulated air into the chamber and through the exit apertures, thereby warming the person's feet. A temperature regulator ensures a normothermic air temperature (or alternatively, hyperthermic air temperature.) Thus, the invention helps relieve or prevent “cold feet” by directing normothermic air at a person's lower extremities. Additionally, by applying heat to the feet and legs, the invention encourages blood flow by virtue of sympathetic vasodilation and local temperature-mediated vasodilation. The invention is also believed to prevent some leg and foot ulcers from forming by maintaining the lower extremity at a near normal temperature during sleep.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

A selective and extended sympathetic nerve block is achieved by administration of a botulinum toxin at and / or around a targeted sympathetic ganglion. The toxin induced sympathetic block finds use for the treatment of sympathetically maintained pain. The toxin induced sympathetic block is also used to treat cardiovascular conditions of sympathetically maintained vasoconstriction; and of undesirable smooth muscle spasm.

An automotive seat cover is provided which allows a person to change the appearance of the seat cover without removing the seat cover from the seat. The seat cover includes panels which are removably attachable to the seat cover to alter the functionality or the visual appearance of the seat cover.

The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Estrene steroid, or a pharmaceutical composition containing an Estrene steroid, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.

The present invention relates to compositions and methods for treating infectious diseases and genetic disorders through gene therapy and intracellular delivery of antisense oligonucleotides or other nucleic acid sequences. In particular, compositions and methods using biologically active nononic reverse block copolymers are described. The reverse copolymers have an inner core of polyoxyethylene (POE) that is flanked on either end by polyoxpropylene (POP). The reverse block copolymers have the following formula: wherein “b” represents a number such that the molecular weight of the hydrophobe (C3H6O)b is between approximately 750 and 20,000 Daltons and “a” represents a number such that the percentage of hydrophile (C2H4O)a is between approximately 1% and 90% of the weight of the block copolymer.

An automotive seat cover is provided which allows a person to change the appearance of the seat cover without removing the seat cover from the seat. The seat cover includes panels which are removably attachable to the seat cover to alter the functionality or the visual appearance of the seat cover.

An improved accessory for an electronic device that allows the device to interface with a standard radio receiver or another electronic device using an incompatible digital transmission format. The accessory includes a digital transceiver for establishing digital communications with a first remote device having a digital transceiver. The accessory receives audio data from the device over the digital wireless channel and produces an FM broadcast output signal based upon the received digital audio data. Thus, music from a personal computer or digital music player can be listened to over a standard radio receiver. The accessory can also be configured to produce a Wi-Fi or Bluetooth formatted output such that the audio data can be transmitted to a previously incompatible radio or headphone receiver. The user inputs of the portable electronic device can preferably be used to control functions of the accessory and the device's display to display the selected transmission frequency or channel of the accessory.

Provided herein are compositions and methods for inhibiting cancer cell motility and / or metastasis. In particular embodiments, KBU2046 (or an analog thereof) and one or more additional therapies (e.g., cancer therapies (e.g., hormone therapies and chemotherapies) are provided to inhibit cancer cell motility, inhibit metastasis, and / or treat cancer (e.g., prostate cancer, lung cancer, breast cancer, colon cancer, etc.).

Several 19-nor-pregnanes are provided which have the capacity to neurochemically alter the hypothalamic function in an individual through nasal administration. These pharmaceutically active compounds can be administered by themselves or in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers to produce the desired effect.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a method includes detecting that a security compromise event has occurred for a mobile device. The method also includes altering a function of the mobile device in response to the security compromise event to mitigate loss of control by an authorized user. Altering the function of the mobile device includes denying access to data stored on the mobile device.

The invention is directed to systems and methods for detecting the loss, theft or unauthorized use of a device and / or altering the functionality of the device in response. In one embodiment, a device monitors its use, its local environment, and / or its operating context to determine that the device is no longer within the control of an authorized user. The device may receive communications or generate an internal signal altering its functionality, such as instructing the device to enter a restricted use mode, a surveillance mode, to provide instructions to return the device and / or to prevent unauthorized use or unauthorized access to data. Additional embodiments also address methods and systems for gathering forensic data regarding an unauthorized user to assist in locating the unauthorized user and / or the device.

The present invention relates to filovirus VLPs and their use in activating innate immunity, specifically natural killer cells, and in enhancing an immune response to an antigen in an animal.

This invention provides a door operator with a wireless setup function and a method for establishing a wireless communication of the door operator, including a wall-mounted device and an operator unit, wherein the wall-mounted device includes a setting switch, a microcontroller, a wireless transmission module and a memory unit; when the setting switch activates the wireless transmission module and is in connection with the external electronic device, the wireless transmission module receives setup information transmitted from the external electronic device in a wireless communication mode, and the microcontroller stores the setup information in the memory unit, and the operator unit is activated in accordance with the setup information. A user may configure / alter the various functions of the door operator easily. As the setting switch has to be turned on before commencing the setup, it prohibits unauthorized access to the door operator, and improves the security of the door operator.

The present invention relates to kinase polypeptides, nucleotide sequences encoding the kinase polypeptides, as well as various products and methods useful for the diagnosis and treatment of various kinase-related diseases and conditions. Through the use of a bioinformatics strategy, mammalian members of the of PTK's and STK's have been identified and their protein structure predicted.